Fig. 3.
Pathological complete response (pCR) rates in non-lymphocyte-predominant breast cancer (non-LPBC) versus LPBC. pCR after neoadjuvant chemotherapy was defined according to Sinn et al. [37].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.